Last updated at 25 Jun 2024 10:40 PM
Director
DIN: 07082183
Shailendra Singh Rawat is currently associated with 2 companies in various capacities such as Additional Director and Designated Partner. They serve as a Director at MEDIGIZER DRUGS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07082183.Shailendra Singh Rawat has previously been associated with 1 company in roles such as Director.Shailendra Singh Rawat is currently involved in 2 different roles. Their most recent position is with CHKMARK E-SOLUTIONS LLP as a Designated Partner. The first company Shailendra Singh Rawat was appointed to was MEDIGIZER DRUGS PRIVATE LIMITED. Shailendra Singh Rawat is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Shailendra Singh Rawat is currently associated with 2 companies in various capacities such as Additional Director and Designated Partner. They serve as a Director at MEDIGIZER DRUGS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07082183.Shailendra Singh Rawat has previously been associated with 1 company in roles such as Director.Shailendra Singh Rawat is currently involved in 2 different roles. Their most recent position is with CHKMARK E-SOLUTIONS LLP as a Designated Partner. The first company Shailendra Singh Rawat was appointed to was MEDIGIZER DRUGS PRIVATE LIMITED. Shailendra Singh Rawat is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
2y 2m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MEDIGIZER DRUGS PRIVATE LIMITED | Additional Director | 29-Jan-2015 |